Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?

The pharmacological implications in blood-brain barrier permeability assays. Drug delivery to the brain is a challenging evaluation to consider during novel compounds discovery stages to study central nervous pharmacokinetics in…

Continuar leyendo Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?

BioPrintIA

  • Autor de la entrada:
  • Categoría de la entrada:NEWS

ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology sector. BioPrintIA is a subsidised R&D project that develops a next-generation medical device based on artificial intelligence,…

Continuar leyendo BioPrintIA

MDCK II cells overexpressing MDR1 protein. A must assay for drug development.

The multidrug resistance protein 1, MDR1 is an efflux transporter that plays an important role in pharmacokinetic activity. This transmembranal transporter regulates the absorption, excretion, and distribution of xenobiotic compounds…

Continuar leyendo MDCK II cells overexpressing MDR1 protein. A must assay for drug development.

Business Developer

  • Autor de la entrada:
  • Categoría de la entrada:NEWS

Readycell es una empresa biotecnológica de Barcelona que desarrolla, implementa y comercializa kits de base celular. Nos encontramos actualmente en una fase de expansión y consolidación y queremos incorporar en…

Continuar leyendo Business Developer